<unk>  is a Antineoplastic, antimetabolite that is FDA approved for the treatment of maintenance therapy of acute lymphatic (lymphocytic, lymphoblastic) leukemia as part of a combination regimen.   Common adverse reactions include Bone marrrow toxicity, Hepatotoxicity, skin rashes, Diarrhoea, nausea, vomiting and anorexia.
Mercaptopurine
Chloroxine
Thiourea
Mafosfamide
Morinamide
Mepenzolate
Hydroxyurea
Vincristine sulfate